The Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertility and Sterility 2008:9(3); S188–S193.Google Scholar

Royal College of Obstetricians and Gynaecologists (RCOG) The Management of Ovarian Hyperstimulation Syndrome Green-top Guideline No. 5 September 2006.Google Scholar

Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland, Directorate of Strategy and Clinical Programmes and Health Service Executive. Clinical Practice Guideline, Ovarian Hyperstimulation Diagnosis and Management 2012.Google Scholar

Joint Society of Obstetricians and Gynaecologists of Canada-Canadian Fertility and Andrology Society Clinical Practice Guidelines Committee. Shmorgun, D, Claman, P, Gysler, M et al. The diagnosis and management of ovarian hyperstimulation syndrome: No. 268, November 2011. Int J Gynaecol Obstet. 2012;116:268–273.Google Scholar

Boothroyd, C, Karia, S, Andreadis, N et al. and The Australasian CREI Consensus Expert Panel on Trial evidence (ACCEPT) group, Consensus statement on prevention and detection of ovarian hyperstimulation syndrome. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2015; 5:523–534. doi:10.1111/ajo.12406Google Scholar

Kwik, M, Karia, S, Boothroyd, C), RANZCOG CREI consensus statement on treatment of ovarian hyperstimulation syndrome. Australian and New Zealand Journal of Obstetrics and Gynaecology, 2015;55:413–419. doi:10.1111/ajo.12389Google Scholar

Mathur, RS, Tan, BK British fertility society policy and practice committee: Prevention of ovarian hyperstimulation syndrome. Human Fertility 2014:17(4);257–268.Google Scholar

Lee, TS, Liu, CH, Huang, CC et al. Serum AMH and estradiol levels as predictors of OHSS in ART cycles. Hum Reprod 2008:23(1);160–167.Google Scholar

Luke, B, Brown, MB, Morbeck, DE et al. Factors associated with OHSS and its effect on ART treatment and outcome. Fertil Steril 2010:94(4);1399–1404.CrossRefGoogle ScholarPubMed

Al-Inany, HG, Youssef, MA, Aboulghar, M et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews, 5, Art. No.:CD001750. Doi:10.1002/14651858.CD001750.pub3.Google Scholar

Tang, T, Glanville, J, Orsi, N et al. The use of metformin for women with PCOS undergoing IVF treatment. Human Reprod 2006:21(26);1416–1425.Google Scholar

Mathur, R, Kailasam, C, Jenkins, J. Review of the evidence base strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil 2007;10:75–85.Google Scholar

Youssef, MA1,Van der, Veen F, Al-Inany, HG et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev 2014 October 31;(10):CD008046. doi:10.1002/14651858.CD008046.pub4.Google Scholar

El-Khayat, W, Elsadek, M. Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial. Fertil Steril 2015:103(1);101–105.Google Scholar

Banker, M, Garcia-Velasco, JA Revisting ovarian hyper stimulation syndrome: towards OHSS free clinic. J Hum Reprod Sci. 2015 January–March;8(1):13–17.Google Scholar